Aperio Group LLC increased its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 81,504 shares of the electronics maker’s stock after buying an additional 1,239 shares during the quarter. Aperio Group LLC’s holdings in Dolby Laboratories were worth $5,053,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of DLB. Janus Henderson Group PLC boosted its holdings in shares of Dolby Laboratories by 352.2% during the third quarter. Janus Henderson Group PLC now owns 2,657,618 shares of the electronics maker’s stock worth $152,875,000 after purchasing an additional 2,069,849 shares during the period. Schroder Investment Management Group acquired a new stake in shares of Dolby Laboratories during the third quarter worth approximately $35,761,000. Sumitomo Mitsui Asset Management Company LTD acquired a new stake in shares of Dolby Laboratories during the fourth quarter worth approximately $22,952,000. TimesSquare Capital Management LLC boosted its holdings in shares of Dolby Laboratories by 6.9% during the third quarter. TimesSquare Capital Management LLC now owns 1,795,000 shares of the electronics maker’s stock worth $103,248,000 after purchasing an additional 116,500 shares during the period. Finally, Alyeska Investment Group L.P. acquired a new stake in shares of Dolby Laboratories during the third quarter worth approximately $4,531,000. Institutional investors and hedge funds own 52.74% of the company’s stock.

In related news, CMO Bob Borchers sold 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $62.72, for a total transaction of $3,136,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Yeaman sold 11,130 shares of the firm’s stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $62.47, for a total transaction of $695,291.10. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 799,085 shares of company stock worth $49,699,604. Insiders own 43.74% of the company’s stock.

Several analysts recently commented on DLB shares. B. Riley set a $66.00 price target on shares of Dolby Laboratories and gave the stock a “buy” rating in a report on Thursday, October 19th. Zacks Investment Research cut shares of Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. raised their price objective on shares of Dolby Laboratories from $63.00 to $70.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $62.00.

Dolby Laboratories, Inc. (DLB) opened at $63.04 on Thursday. The firm has a market cap of $6,530.00, a P/E ratio of 100.06, a P/E/G ratio of 5.26 and a beta of 0.78. Dolby Laboratories, Inc. has a 52-week low of $48.00 and a 52-week high of $74.29.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.35. The firm had revenue of $287.80 million for the quarter, compared to analyst estimates of $265.75 million. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.66 earnings per share. equities analysts predict that Dolby Laboratories, Inc. will post 0.99 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 14th. Investors of record on Monday, February 5th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend was Friday, February 2nd. Dolby Laboratories’s payout ratio is presently 101.59%.

COPYRIGHT VIOLATION NOTICE: “Aperio Group LLC Boosts Position in Dolby Laboratories, Inc. (DLB)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/02/15/aperio-group-llc-boosts-position-in-dolby-laboratories-inc-dlb.html.

Dolby Laboratories Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLB).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.